Colofort tablets for resorption, # 100

Colofort tab.

d / resorption No. 100

Name ENG

KOLOFORT

Clinical and pharmacological group

Antispasmodics in combination with psychotropic drugs

ATX code

Drugs used for disorders of intestinal function

Drugs acting on serotonin receptors

Antispasmodics in combination with psycholeptics

Dosage

6mg + 6mg + 6mg

Structure

Active substances:

Antibodies to human tumor necrosis factor alpha affinity purified - 0.006 g *.

Affinity purified antibodies to brain-specific protein S-100 - 0.006 g *.

Affinity purified antibodies to histamine - 0.006 g *.

Excipients: lactose monohydrate, microcrystalline cellulose, magnesium stearate.

* applied to lactose as a mixture of three active water-alcohol dilutions

substance, diluted respectively in 100

Description

12 30 200

, 100, 100 times. "

Indications

Irritable bowel syndrome

functional disorders of the gastrointestinal tract.

Storage conditions and periods

In a dark place at a temperature not exceeding 25 degrees.

Expiration date: 3 years

Contraindications

Increased individual sensitivity to drug components.

Age under 18.

Lactase deficiency, lactose intolerance, glucose-galactose malabsorption.

INN / Active ingredient

Homeopathic composition

Specifications

Category

Preparations for the gastrointestinal tract

Scope of the drug

Gastrointestinal tract

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

one hundred

Scope of application

Gastroenterology

Minimum age from

18 years

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Materia Medica Holding

The amount of the dosage form in the primary package

20 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Anti-inflammatory agent

Dosage form

Lozenges

Expiration date in days

1095

Package weight, g

thirty

Mode of application

:

Colofort is taken orally.

At one time - 1 or 2 tablets (keep in the mouth until completely dissolved - not during meals).

Take 2 times a day.

The course of treatment is 1-3 months

if necessary, the course of treatment can be extended up to 6 months and / or repeated after 1-2 months.

Against the background of an exacerbation of diseases, it is possible to increase the frequency of administration up to 4 times a day for a period of 7 to 14 days.

Anatomical and therapeutic characteristics

:

A03A Drugs for the treatment of functional bowel disorders

Dosage (volume) of the substance in the preparation

:

antibodies to human TNF-α?

affinity purified * 0.006 g, antibodies to brain-specific protein S-100 affinity purified * 0.006 g, antibodies to histamine affinity purified * 0.006 g

"